For the complete documentation index, see llms.txt. This page is also available as Markdown.

Biological Classification

The Biological Classification section of the Biomarker Details page summarizes all biological assertions previously created for the variant across all sources (i.e., My Knowledge Base, OncoKB, CKB).

If you have existing knowledge to upload to the system, refer to Upload Assertions.

You can filter assertions by source, diseases, and summary. Filter changes are saved and applied across variants within a case and can be reset if needed.

Assertion Details

Field Name

Description

Directional Arrows

Opens to view the assertion summary and update date.

Biomarker

Indicates how the assertion is related to the variant (for example, specific amino acid change or specific exon change).

HRD

Indicates whether an assertion is associated with HRD positive or negative. This column is available for GIS and variants when the selected transcript is for BRCA1/2.

Classification

This column displays the classification as indicated by the knowledge base.

Type

The assertion type (for example, biological). For more information, refer to Interpret a Variant.

Disease

The disease associated with the classification.

Previously Reported Icon

Any cases where the assertion was previously reported.

Actions

This column contains the following available actions: • Add to report • Archive, if the assertion is in My Knowledge Base • Copy to New Assertion, if the assertion is not in My Knowledge Base

To edit an assertion, add it to the report before editing. For more information, refer to Manage Assertions.

Available Knowledge Bases

Memorial Sloan Kettering OncoKB

Connected Insights provides the Memorial Sloan Kettering OncoKB. For more information, refer to the OncoKB website. See this page for classification descriptions.

The following from OncoKB is not supported:

  • Predictions based on similar variants / hotspots (e.g., https://www.oncokb.org/gene/PIK3CA/somatic/P449_L452del)

  • Non-compliant HGVS

  • Unspecified positions: Epigenetic Silencing (e.g., CDH1), AR v567es, DNMT3B DNMT3B7, EGFR vII, Overexpression (e.g., EZH2), Wildtype (e.g., KRAS, NRAS), Promoter Hypermethylation (e.g., CASP8, PTPRT), Hypermethylation (e.g., CDKN2B), Kinase Domain Duplication (e.g., EGFR)

Genomenon Cancer Knowledge Base (CKB)

Connected Insights provides the Genomenon Cancer Knowledge Base (formerly Jackson Laboratory Clinical Knowledge Base). For more information, refer to the Genomenon CKB website. See this page for assertion descriptions.

The following from CKB is not supported:

  • Emerging and risk factor evidence types

  • Class # (e.g., BRAF), over exp, dec exp, hypermethylation (e.g., MGMT), dup exonX (e.g., EGFR), dup exonX-X (e.g., EGFR, FGFR2), loss, and wild type variants.

Clinical Interpretation of Variants in Cancer (CIViC)

Connected Insights also provides the Clinical Interpretation of Variants in Cancer (CIViC) knowledge base. For more information, refer to the CIViC website. See this page for evidence descriptions.

The following from CIViC is not supported:

  • Assertions

  • Functional and oncogenic evidence types

  • MET Splice Site (c.3028G>A), Boolean-like evidence (for example, (V600E or V600K) and Amplification), Underexpression, Overexpression, Decreased Peri-therapeutic Expression (e.g., VEGFA), Cytoplasmic Expression (e.g., FGF13), Loss, Biallelic Inactivation (e.g., PALB2, CEBPA), Alu Insertion (e.g., BRCA1), Alternative Transcript (e.g., ALK, BAP1), RSID, Homozygosity (e.g., DPYD), Copy-neutral Loss of Heterozygosity (e.g., HLA-C), Deleterious Mutation (e.g., TP53), Double Ph (e.g., ABL1), Wildtype, Domain, Exon-specific fusions

Last updated

Was this helpful?